These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 17823925

  • 1. Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms.
    Gill C, Walsh SE, Morrissey C, Fitzpatrick JM, Watson RW.
    Prostate; 2007 Nov 01; 67(15):1641-53. PubMed ID: 17823925
    [Abstract] [Full Text] [Related]

  • 2. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells.
    Pfeil K, Eder IE, Putz T, Ramoner R, Culig Z, Ueberall F, Bartsch G, Klocker H.
    Prostate; 2004 Feb 15; 58(3):259-68. PubMed ID: 14743465
    [Abstract] [Full Text] [Related]

  • 3. Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway.
    Sheth S, Jajoo S, Kaur T, Mukherjea D, Sheehan K, Rybak LP, Ramkumar V.
    PLoS One; 2012 Feb 15; 7(12):e51655. PubMed ID: 23272133
    [Abstract] [Full Text] [Related]

  • 4. SOCS-3 antagonizes pro-apoptotic effects of TRAIL and resveratrol in prostate cancer cells.
    Horndasch M, Culig Z.
    Prostate; 2011 Sep 15; 71(12):1357-66. PubMed ID: 21308719
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Corn silk maysin induces apoptotic cell death in PC-3 prostate cancer cells via mitochondria-dependent pathway.
    Lee J, Lee S, Kim SL, Choi JW, Seo JY, Choi DJ, Park YI.
    Life Sci; 2014 Dec 05; 119(1-2):47-55. PubMed ID: 25445226
    [Abstract] [Full Text] [Related]

  • 9. Effect of diallyl disulfide on insulin-like growth factor signaling molecules involved in cell survival and proliferation of human prostate cancer cells in vitro and in silico approach through docking analysis.
    Arunkumar R, Sharmila G, Elumalai P, Senthilkumar K, Banudevi S, Gunadharini DN, Benson CS, Daisy P, Arunakaran J.
    Phytomedicine; 2012 Jul 15; 19(10):912-23. PubMed ID: 22739413
    [Abstract] [Full Text] [Related]

  • 10. Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins.
    Aziz MH, Nihal M, Fu VX, Jarrard DF, Ahmad N.
    Mol Cancer Ther; 2006 May 15; 5(5):1335-41. PubMed ID: 16731767
    [Abstract] [Full Text] [Related]

  • 11. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
    Shukla S, Maclennan GT, Hartman DJ, Fu P, Resnick MI, Gupta S.
    Int J Cancer; 2007 Oct 01; 121(7):1424-32. PubMed ID: 17551921
    [Abstract] [Full Text] [Related]

  • 12. Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway.
    Nguyen DM, Chen GA, Reddy R, Tsai W, Schrump WD, Cole G, Schrump DS.
    J Thorac Cardiovasc Surg; 2004 Feb 01; 127(2):365-75. PubMed ID: 14762343
    [Abstract] [Full Text] [Related]

  • 13. Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB.
    Pozo-Guisado E, Merino JM, Mulero-Navarro S, Lorenzo-Benayas MJ, Centeno F, Alvarez-Barrientos A, Fernandez-Salguero PM.
    Int J Cancer; 2005 May 20; 115(1):74-84. PubMed ID: 15688415
    [Abstract] [Full Text] [Related]

  • 14. Antiproliferative effects of resveratrol and the mediating role of resveratrol targeting protein NQO2 in androgen receptor-positive, hormone-non-responsive CWR22Rv1 cells.
    Hsieh TC.
    Anticancer Res; 2009 Aug 20; 29(8):3011-7. PubMed ID: 19661309
    [Abstract] [Full Text] [Related]

  • 15. Effects of cIAP-1, cIAP-2 and XIAP triple knockdown on prostate cancer cell susceptibility to apoptosis, cell survival and proliferation.
    Gill C, Dowling C, O'Neill AJ, Watson RW.
    Mol Cancer; 2009 Jun 23; 8():39. PubMed ID: 19549337
    [Abstract] [Full Text] [Related]

  • 16. Sensitization to gimatecan-induced apoptosis by tumor necrosis factor-related apoptosis inducing ligand in prostate carcinoma cells.
    Perego P, Ciusani E, Gatti L, Carenini N, Corna E, Zunino F.
    Biochem Pharmacol; 2006 Mar 14; 71(6):791-8. PubMed ID: 16438941
    [Abstract] [Full Text] [Related]

  • 17. Isorhapontigenin induced cell growth inhibition and apoptosis by targeting EGFR-related pathways in prostate cancer.
    Zhu C, Zhu Q, Wu Z, Yin Y, Kang D, Lu S, Liu P.
    J Cell Physiol; 2018 Feb 14; 233(2):1104-1119. PubMed ID: 28422286
    [Abstract] [Full Text] [Related]

  • 18. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
    Martelli AM, Tazzari PL, Tabellini G, Bortul R, Billi AM, Manzoli L, Ruggeri A, Conte R, Cocco L.
    Leukemia; 2003 Sep 14; 17(9):1794-805. PubMed ID: 12970779
    [Abstract] [Full Text] [Related]

  • 19. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer.
    Chen X, Thakkar H, Tyan F, Gim S, Robinson H, Lee C, Pandey SK, Nwokorie C, Onwudiwe N, Srivastava RK.
    Oncogene; 2001 Sep 20; 20(42):6073-83. PubMed ID: 11593415
    [Abstract] [Full Text] [Related]

  • 20. Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells.
    Chen Q, Ganapathy S, Singh KP, Shankar S, Srivastava RK.
    PLoS One; 2010 Dec 14; 5(12):e15288. PubMed ID: 21179458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.